Board of Directors

Christopher B. Begley

Retired Executive Chairman and Chief Executive Officer, Hospira, Inc.

Christopher B. Begley

Retired Executive Chairman and Chief Executive Officer, Hospira, Inc.

Director Since 2012

Executive Chairman of the Board of Hospira, Inc. from May 2007 until his retirement in January 2012. Mr. Begley also served as Chief Executive Officer from April 30, 2004, when Hospira was spun off from Abbott Laboratories, to March 2011. Prior to that, Mr. Begley served in various positions with Abbott between 1986 and 2004, most recently as Senior Vice President of Abbott’s Hospital Products division. He earned a bachelor’s degree from Western Illinois University and an MBA from Northern Illinois University.

Other Public Board Memberships

Hanger, Inc. (Chairman of the Board)
Past director and Non-Executive Chairman of Adtalem Global Education Inc. (formerly known as DeVry Education Group Inc.) (until November 2017)

Other Relevant Experience

Past director of the Advanced Medical Technology Association (“AdvaMed”), the medical device industry’s trade association

Member of the Compensation and Management Development Committee

Chair of the Quality, Regulatory and Technology Committee

Betsy J. Bernard

Retired President, AT&T Corp.

Betsy J. Bernard

Retired President, AT&T Corp.

Director Since 2009

President of AT&T Corp. from October 2002 until her retirement in December 2003. From April 2001 to October 2002, Ms. Bernard was Chief Executive Officer of AT&T Consumer. Prior to joining AT&T, Ms. Bernard held senior executive positions with Qwest Communications International Inc., US WEST, Inc., AVIRNEX Communications Group and Pacific Bell. Ms. Bernard received a B.A. degree from St. Lawrence University, an MBA from Fairleigh Dickenson University and an M.S. in management from Stanford University’s Sloan Fellowship Program.

Other Public Board Memberships

Past director of Principal Financial Group, Inc. (until May 2020)
Past director of SITO Mobile Ltd. (until June 2017)

Member of the Audit Committee

Chair of the Corporate Governance Committee

Gail K. Boudreaux

President and Chief Executive Officer, Anthem, Inc.

Gail K. Boudreaux

President and Chief Executive Officer, Anthem, Inc.

Director Since 2012

President and Chief Executive Officer, Anthem, Inc. Previously, Ms. Boudreaux served as Chief Executive Officer and Founder, GKB Global Health, LLC. Prior to that, she served as Chief Executive Officer of UnitedHealthcare from January 2011 to November 2014 and Executive Vice President of UnitedHealth Group from May 2008 to February 2015. From 2005 to 2008, Ms. Boudreaux served as Executive Vice President, External Operations for Health Care Services Corporation (“HCSC”), and prior to that served as President of Blue Cross and Blue Shield of Illinois, a division of HCSC. Before joining HCSC, Ms. Boudreaux held various positions at Aetna, including Senior Vice President, Aetna Group Insurance. Ms. Boudreaux earned a bachelor's degree in psychology from Dartmouth College and an MBA from Columbia Business School.

Other Public Board Memberships

Anthem, Inc.
Past director of Xcel Energy Inc. (until December 2017)
Past director of Novavax, Inc. (until November 2017)

Member of the Audit Committee

Member of the Corporate Governance Committee

Michael J. Farrell

Chief Executive Officer, ResMed Inc.

Michael J. Farrell

Chief Executive Officer, ResMed Inc.

Director Since 2014

Chief Executive Officer of ResMed Inc. since March 2013. Prior to that appointment, Mr. Farrell served as President – Americas for ResMed from 2011 to 2013. He was previously Senior Vice President of the global business unit for sleep apnea therapeutic and diagnostic devices from 2007 to 2011, and before that he held various senior roles in marketing and business development. Before joining ResMed in September 2000, Mr. Farrell worked in management consulting, biotechnology, chemicals and metals manufacturing at Arthur D. Little, Genzyme Corporation, The Dow Chemical Company and BHP Billiton. Mr. Farrell holds a bachelor of engineering, with first-class honors, from the University of New South Wales, a master of science in chemical engineering from the Massachusetts Institute of Technology and an MBA from the MIT Sloan School of Management.

Other Public Board Memberships

ResMed Inc.

Other Relevant Experience

Director of AdvaMed

Member of the Compensation and Management Development Committee

Member of the Quality, Regulatory and Technology Committee

Larry C. Glasscock

Chairman of the Board of Zimmer Biomet Holdings, Inc.
Retired Chairman, President and Chief Executive Officer, Anthem, Inc.

Larry C. Glasscock

Chairman of the Board of Zimmer Biomet Holdings, Inc.
Retired Chairman, President and Chief Executive Officer, Anthem, Inc.

Director Since 2001; Non-Executive Chairman Since May 2013

Chairman of WellPoint, Inc. (now Anthem, Inc.) from 2005 until 2010. Mr. Glasscock also served as President and Chief Executive Officer of WellPoint, Inc. from 2004 to 2007. Mr. Glasscock served as Chairman, President and Chief Executive Officer of Anthem, Inc. from 2003 to 2004 and served as President and Chief Executive Officer of Anthem, Inc. from 2001 to 2003. Mr. Glasscock earned a B.B.A. from Cleveland State University. He also completed the Commercial Bank Management Program at Columbia University.

Other Public Board Memberships

Simon Property Group, Inc. (Lead Independent Director)
Sysco Corporation

Member of the Audit Committee

Member of the Corporate Governance Committee

Robert A. Hagemann

Retired Senior Vice President and Chief Financial Officer, Quest Diagnostics Incorporated

Robert A. Hagemann

Retired Senior Vice President and Chief Financial Officer, Quest Diagnostics Incorporated

Director Since 2008

Senior Vice President and Chief Financial Officer of Quest Diagnostics Incorporated until his retirement in July 2013. Mr. Hagemann joined Corning Life Sciences, Inc., a subsidiary of Quest Diagnostics’ former parent company, Corning Incorporated, in 1992, and held roles of increasing responsibility before being appointed Chief Financial Officer of Quest Diagnostics in 1998. Prior to joining Corning, Mr. Hagemann held senior financial positions at Prime Hospitality, Inc. and Crompton & Knowles, Inc. He was also previously employed by Arthur Young & Co., a predecessor company to Ernst & Young. Mr. Hagemann holds a B.S. in accounting from Rider University and an MBA from Seton Hall University.

Other Public Board Memberships

Graphic Packaging Holding Company
Ryder System, Inc.

Chair of the Audit Committee

Member of the Corporate Governance Committee

Bryan C. Hanson

President and Chief Executive Officer, Zimmer Biomet Holdings, Inc.

Bryan C. Hanson

President and Chief Executive Officer, Zimmer Biomet Holdings, Inc.

Director Since 2017

Bryan C. Hanson was appointed President and Chief Executive Officer and a member of the Board of Directors of Zimmer Biomet in December 2017.

Prior to joining Zimmer Biomet, Mr. Hanson served as a member of Medtronic’s Executive Committee and as Executive Vice President and Group President, Minimally Invasive Therapies Group of Medtronic, where he oversaw and provided strategic direction to that approximately $9 billion business. Prior to joining Medtronic, Mr. Hanson served as Group President, Covidien, with global responsibility for all Covidien business segments. Prior to being elevated to that newly created position, Mr. Hanson served as Group President, Medical Devices & U.S. of Covidien and prior to that, he served as Group President, Surgical Solutions and President, Energy-based Devices. Mr. Hanson began his career with Covidien in 1992. He holds a Bachelor of Science degree in Finance from Florida State University. He also completed the Kellogg School of Management Finance for Executives program in 2010 and the Harvard Executive Education in Leadership program in 2013. Mr. Hanson serves on the board of AmeriCares, an emergency response and global health organization committed to saving lives and building healthier futures for people in crisis.

Arthur J. Higgins

Consultant, Blackstone Healthcare Partners

Arthur J. Higgins

Consultant, Blackstone Healthcare Partners

Director Since 2007

Consultant, Blackstone Healthcare Partners of The Blackstone Group since June 2010. Mr. Higgins served as Non-Executive Chairman of the Board of Assertio Holdings, Inc., successor issuer to Assertio Therapeutics, Inc., from May 2020 until December 2020. Prior to that, he served as President and Chief Executive Officer and a member of the board of directors of Assertio Therapeutics, Inc. from March 2017 until its merger with Zyla Life Sciences in May 2020. Previously, Mr. Higgins served as Chairman of the Board of Management of Bayer HealthCare AG from January 2006 to May 2010 and Chairman of the Bayer HealthCare Executive Committee from July 2004 to May 2010. Prior to joining Bayer HealthCare in 2004, Mr. Higgins served as Chairman, President and Chief Executive Officer of Enzon Pharmaceuticals, Inc. from 2001 to 2004. Prior to that, Mr. Higgins spent 14 years with Abbott Laboratories, most recently as President of the Pharmaceutical Products Division from 1998 to 2001. He graduated from Strathclyde University, Scotland and holds a B.S. in biochemistry.

Other Public Board Memberships

Ecolab Inc.
Past director of Assertio Holdings, Inc. (until December 2020)
Past director of Assertio Therapeutics, Inc. (until May 2020)
Past director of Endo International plc (until March 2017)

Chair of the Compensation and Management Development Committee

Member of the Quality, Regulatory and Technology Committee

Maria Teresa Hilado

Retired Executive Vice President and Chief Financial Officer, Allergan plc

Maria Teresa Hilado

Retired Executive Vice President and Chief Financial Officer, Allergan plc

Director Since 2018

Executive Vice President and Chief Financial Officer of Allergan plc, a global pharmaceutical company, from December 2014 until her retirement in February 2018. Prior to joining Allergan, Ms. Hilado served as Senior Vice President, Finance and Treasurer of PepsiCo Inc. from 2009 until 2014. She previously served as Vice President and Treasurer for Schering-Plough Corp. from 2008 to 2009 and spent more than 17 years with General Motors Co. in leadership roles of increasing responsibility, including Assistant Treasurer from 2006 to 2008 and Chief Financial Officer, GMAC Commercial Finance LLC from 2001 to 2005. She began her career with Far East Bank and Trust Co. in Manila, Philippines. Ms. Hilado earned a Bachelor’s degree in Management Engineering from Ateneo de Manila University in the Philippines and an MBA from the University of Virginia Darden School of Business.

Other Public Board Memberships

Campbell Soup Company
H.B. Fuller Company
PPD, Inc

Member of the Audit Committee
Member of the Corporate Governance Committee

Syed Jafry

Senior Vice President and President, Regions, Thermo Fisher Scientific, Inc.

Syed Jafry

Senior Vice President and President, Regions, Thermo Fisher Scientific, Inc.

Director Since 2018

Senior Vice President and President, Regions, Thermo Fisher Scientific, Inc. since September 2017. Mr. Jafry is responsible for all business geographies outside the U.S. He joined Thermo Fisher Scientific in March 2005 and served in numerous roles of increasing responsibility prior to being appointed to his current position. Mr. Jafry started his career at Glaxo Pharmaceuticals in London. Prior to joining Thermo Fisher Scientific, he served for 18 years at General Electric, where he held commercial, product management and general management roles in the U.S., Netherlands, Switzerland and China, most recently serving as President of GE Sensing Asia. Mr. Jafry holds a Master’s degree in Mechanical Engineering from the University of Massachusetts, a Master’s certificate in Marketing and Management from Harvard University Extension School and a Bachelor’s degree in Mechanical Engineering from Lahore University in Pakistan.

Member of the Compensation and Management Development Committee
Member of the Quality, Regulatory and Technology Committee

Sreelakshmi Kolli

Senior Vice President, Chief Digital Officer, Align Technology, Inc.

Sreelakshmi Kolli

Senior Vice President, Chief Digital Officer, Align Technology, Inc.

Director since 2021

Senior Vice President, Chief Digital Officer of Align Technology, Inc., a global medical device company (“Align”), since April 2020. Ms. Kolli is responsible for leading software, data, enterprise, cloud and infrastructure engineering teams focused on design and development of digital products and services. This includes defining the technology strategy and development of product software, consumer, customer, manufacturing and enterprise applications enabling the Align Digital Platform. In addition, she led Align’s global business transformation initiative aimed at delivering platforms and technology to support customer experience and simplified business processes across the company. She joined Align in June 2003 and has held positions of increasing responsibility leading business operations and engineering for customer-facing applications during her tenure. She was promoted to Vice President, Information Technology in December 2012 and to Senior Vice President, Global Information Technology in February 2018. Prior to joining Align, Ms. Kolli held technical lead positions with Citadon and Accenture. She is a member of the Executive Advisory Board at Salesforce.com and an external advisor on the Board of Trustees Committee on Information Technology at the University of San Francisco. Ms. Kolli earned an M.S. degree in Computer Applications at the National Institute of Technology in Trichy, India and is a graduate of the Stanford Executive Program offered by the Stanford Graduate School of Business in California.

Michael W. Michelson

Retired Senior Advisory Partner, KKR Management LLC, the general partner of KKR & Co. L.P.

Michael W. Michelson

Retired Senior Advisory Partner, KKR Management LLC, the general partner of KKR & Co. L.P.

Director Since 2015

Senior Advisory Partner, KKR Management LLC, a private equity investment manager and the general partner of KKR & Co. L.P., from January 2018 until his retirement in January 2020. Previously, Member, KKR Management LLC since October 2009. Before that, Mr. Michelson was a member of the limited liability company that served as the general partner of Kohlberg Kravis Roberts & Co. L.P. since 1996. He joined KKR in 1981. Mr. Michelson has played a significant role in the development of KKR’s portfolio companies. He began his professional career with the law firm of Latham & Watkins in Los Angeles, where he was involved in a broad corporate practice while specializing in management buyouts. He earned an A.B. from Harvard College and a J.D. from Harvard Law School.

Other Public Board Memberships

HCA Healthcare, Inc.

Other Relevant Experience

Served as a director of Biomet prior to the merger of Zimmer and Biomet

Member of the Compensation and Management Development Committee

Member of the Quality, Regulatory and Technology Committee